ORYZF
Oryzon Genomics S.A.
CEO
Carlos Manuel Buesa Arjol
Industry
Research and Development in Biotechnology
Loading...
Open
3.10
Mkt cap
201M
Volume
15K
High
3.10
P/E Ratio
-44.29
52-wk high
3.10
Low
3.10
Div yield
N/A
52-wk low
1.41
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.